- POSITIVE
Quarterly Revenue Innova Captab Jun-2026 Quarterly Revenue is Rs 403 Cr which is growth of 38.4% YoY.
- POSITIVE
Quarterly Net Profit Innova Captab Jun-2026 Quarterly Net Profit is Rs 32 Cr which is growth of 58.0% YoY.
NSE: INNOVACAP | BSE: 544067
Innova Captab Live Share Price Today, Share Analysis and Chart
aboutInnova Captab Ltd. is a vertically integrated pharmaceutical company with a presence across the entire value chain, including research and development (R&D), manufacturing, and marketing. The company operates in three primary business segments: Contr... Read More
1013.00-12.30(-1.20%)
6,907
NSE+BSE Volume
NSE 02 Nov, 2026 10:14 AM (IST)
Turnaround PotentialThese stocks have average financials and valuation, but strong momentum indicating buying interestView SimilarEmbed DVM
Please subscribe to view forecaster data
Innova Captab Stock Price Analysis
Day Price Range-1.2% 1 Day return | 1013 (LTP) 994.61,024 LowHigh |
|---|---|
Week Price Range2.6% 1 Week return | 1013 (LTP) 969.71,093.9 LowHigh |
Month Price Range-13.3% 1 Month return | 1013 (LTP) 9521,193 LowHigh |
52 Week Price Range21.9% 1 Year return | 1013 (LTP) 6221,353.5 LowHigh |
Innova Captab Forecaster - Analyst Share Price Target and Estimates
Revenue forecast
EPS forecast
CURRENT EPS
AVG. ESTIMATE
Consensus Recommendation
2 ANALYST Recommendations
BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Forecaster
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Innova Captab quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 403.2 | 361 | 366.9 | 294.5 | 291.3 | 246.9 | 252 | 244.5 | 231.5 | 204.1 | 238.2 | 213.8 | 219.5 | ||
Operating Exp. | 346.4 | 319.6 | 316.7 | 260.5 | 252.2 | 214.3 | 216 | 207 | 198.4 | 174.7 | 205.9 | 185.5 | 190.9 | |
Operating Profit | 54.1 | 38.6 | 47 | 29.3 | 34.8 | 28.2 | 32.5 | 33.2 | 28.5 | 23.4 | 30.5 | 26.3 | 27.8 | |
Operating Profit Margin % | 13.50% | 10.78% | 12.92% | 10.12% | 12.13% | 11.62% | 13.07% | 13.82% | 12.54% | 11.81% | 12.91% | 12.41% | 12.70% | |
Depr. | 9.7 | 9.4 | 9.4 | 9.5 | 9.1 | 7.8 | 3.1 | 3.1 | 3.1 | 2.9 | 3 | 2.8 | 2.7 | |
Interest | 4 | 4 | 3.5 | 5.2 | 2.8 | 1.9 | 0.1 | 0.1 | 0.1 | 0.1 | 3.8 | 5.2 | 4.5 | |
Profit Before Tax | 43 | 27.9 | 37.3 | 19.3 | 27.3 | 22.9 | 32.8 | 34.3 | 29.9 | 26.4 | 25.5 | 20.4 | 21.5 | |
Tax | 11 | 6.8 | 9.4 | 4.9 | 7 | 5.7 | 8.4 | 8.7 | 7.6 | 6.6 | 6.9 | 5.9 | 6.1 | |
Net Profit | 32.1 | 21.2 | 27.9 | 14.3 | 20.3 | 17.1 | 24.4 | 25.6 | 22.3 | 19.7 | 18.7 | 14.5 | 15.3 | |
EPS Adj. latest | 5.6 | 3.7 | 4.9 | 2.5 | 3.6 | 3 | 4.3 | 4.5 | 3.9 | 3.5 | 3.3 | 2.5 | 2.7 | |
Net profit TTM | 95.5 | 83.7 | 79.7 | 76.2 | 87.4 | 89.5 | 92.1 | 86.3 | 75.2 | 68.2 | 61.9 | 59.4 | 62 | |
Basic EPS TTM | 16.7 | 14.6 | 13.9 | 13.3 | 15.3 | 15.6 | 16.1 | 15.1 | 13.1 | 11.9 | 10.8 | 12.4 | 12.9 | |
Earnings Transcripts | ||||||||||||||
AI Summary | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Innova Captab Technical Analysis
Innova Captab EMA & SMA
Bearish-6
1 bullish, 7 bearish
Bullish1
Bearish7
| 5 Day | 1033.5 |
|---|---|
| 10 Day | 1036.8 |
| 12 Day | 1041.5 |
| 20 Day | 1061.9 |
| 26 Day | 1072.3 |
|---|---|
| 50 Day | 1077.2 |
| 100 Day | 1031.2 |
| 200 Day | 954.1 |
Innova Captab Delivery And Volume
Daily Avg. Delivery Volume %
30 Oct, 202637.5%
Week43.4%
Month45.2%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Innova Captab Resistance and Support
1034.23
Pivot
| First Resistance | 1058.8 |
|---|---|
| Second Resistance | 1092.2 |
| Third Resistance | 1116.8 |
| First Support | 1000.8 |
|---|---|
| Second Support | 976.2 |
| Third Support | 942.8 |
| Day RSI | 41.1 |
|---|---|
| Day MACD | -30.8 |
| Day MFI | 23.1 |
| Day MACD Signal Line | -30.9 |
Innova Captab Beta
| 1 Month | 0.1 |
|---|---|
| 1 Year | 0.4 |
| 3 Month | 0.1 |
|---|---|
| 3 Year | - |
Innova Captab Price Change Analysis
↓-13.3%
Over 1 Month
LowHigh
9521193
↑4.0%
Over 3 Months
LowHigh
925.21353.5
↑34.7%
Over 6 Months
LowHigh
7901353.5
↑21.9%
Over 1 Year
LowHigh
6221353.5
Innova Captab Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SBI MUTUAL FUND | Bulk | Purchase | 30 Sep 2026 | 1080 | 833,250 | BSE |
| GIAN PARKASH AGGARWAL | Bulk | Sell | 30 Sep 2026 | 1080.04 | 1,550,000 | BSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 02 Jan 2024 | 565.55 | 345,941 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 02 Jan 2024 | 566 | 345,941 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 01 Jan 2024 | 525.70 | 477,528 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 01 Jan 2024 | 525.68 | 477,528 | NSE |
| MANSI SHARE AND STOCK ADVISORS PVT LTD | Bulk | Sell | 29 Dec 2023 | 535.24 | 765,523 | NSE |
| MUSIGMA SECURITIES | Bulk | Sell | 29 Dec 2023 | 508.32 | 461,621 | NSE |
| ELIXIR WEALTH MANAGEMENT PRIVATE LIMITED | Bulk | Sell | 29 Dec 2023 | 512.06 | 283,277 | NSE |
| GOLDMINE STOCKS PRIVATE LIMITED | Bulk | Sell | 29 Dec 2023 | 502.89 | 359,567 | NSE |
Innova Captab Corporate Actions
Innova Captab Dividend history and yield
Innova Captab dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Innova Captab dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
130 Jan 2026 | 2 | INTERIM | 30 Jan 2026 | Equity Share |
Innova Captab Board Meetings
Innova Captab past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
121 Aug 2026 | Audited Results | - |
211 Aug 2026 | Quarterly Results | - |
307 May 2026 | Audited Results | - |
423 Jan 2026 | Quarterly Results, Dividend & Others | To consider other business matters. |
507 Nov 2025 | Quarterly Results | - |
Innova Captab Research Reports
Innova Captab research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 118 Oct 2024 | BP Wealth | 865 | 746 | Buy | 15.95% | 35.79% | |
| 219 Dec 2023 | SBI Securities | - | - | IPO Subscribe | - | -% | |
| 319 Dec 2023 | Hem Securities | - | - | IPO Subscribe | - | -% | |
| 419 Dec 2023 | Ventura | - | - | IPO Subscribe | - | -% |
Innova Captab Corporate Filings
Innova Captab BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 07 Oct 2026 | Innova Captab Ltd - 544067 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Pursuant to regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the certificate dated 07th October, 2026 received from KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2026. | |
| 05 Oct 2026 | Innova Captab Ltd - 544067 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gian Parkash Aggarwal & PACs | |
| 02 Oct 2026 | Innova Captab Ltd - 544067 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | We wish to inform you that 22nd Annual General Meeting ("AGM") of the Company was held on Wednesday, 30th September, 2026 at 11.00 A.M. through Video Conferencing ("VC") / Other Audio Visual means ("OAVM") in accordance with the circular(s) issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Pursuant to applicable provisions of the Lising Regulations, we enclosed herewith details of Voting Results pursuant to regulation 44 of Listing Regulations and Scrutinizer Report. | |
| 30 Sep 2026 | Innova Captab Ltd - 544067 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Pursuant to the provisions of regulation 30 read with part A of schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed a summary of the proceedings of the 22nd Annual General Meeting ("AGM") of Innova Captab Limited held today i.e. 30th September, 2026 at 11:00 A.M. (IST) through Video Conferencing/ Other Audio-Visual Means ("VC/OAVM"). The AGM concluded at 11:30 A.M. (IST). | |
| 29 Sep 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Credit Rating | Pursuant to regulation 30 read with part A of schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that M/s. CARE Ratings Limited, a credit rating agency, has revised the credit ratings on banking facilities of the Company. A copy of the rating letter including all requisite details is enclosed. |
Innova Captab Documents
Innova Captab Earnings Call
Innova Captab earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 14 Aug 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 14 May 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 02 Feb 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 02 Feb 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 27 Jan 2026 | Innova Captab Results Earnings Call for Q3FY26 | AudioVideo |
Innova Captab Annual Reports
Innova Captab financials, including annual results, balance sheets, and cash flow statements.
Innova Captab Credit Ratings
Innova Captab credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
Innova Captab Investor Presentations
Innova Captab investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 07 May 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 23 Jan 2026 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 07 Nov 2025 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 07 Aug 2025 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 19 May 2025 | Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Innova Captab - Company Profile
Innova Captab Management Structure
Innova Captab management structure with salaries, total experience, and qualifications.
Innova Captab Board of Directors
Innova Captab Board of directors with salaries, total experience, and qualifications.
Website: www.innovacaptab.com
About the company - Business Profile
Innova Captab Ltd. is a vertically integrated pharmaceutical company with a presence across the entire value chain, including research and development (R&D), manufacturing, and marketing. The company operates in three primary business segments: Contract Development and Manufacturing Organization (CDMO) services, domestic branded generics, and international branded generics. As of FY25, Innova Captab serves over 200 CDMO customers, including some of India's leading pharmaceutical companies, and maintains a vast distribution network across India.
Key Points
- Key Facts: Founded in 2005 and headquartered in Mumbai, Maharashtra (Registered Office) and Panchkula, Haryana (Corporate Office), Innova Captab is listed on the BSE and NSE. The company is led by promoters Manoj Kumar Lohariwala and Vinay Kumar Lohariwala.
- Operations and Resources: The company operates manufacturing units in Baddi (Himachal Pradesh) and has recently commercialized a facility in Kathua, Jammu in January 2025. It also operates an API manufacturing unit in Taloja and is operationalizing a second R&D center in Panchkula, Haryana, by H2 FY2026.
- Privatization and Ownership: The company is promoter-led, with the Lohariwala family holding significant control. Major milestones include the acquisition of Sharon Bio-Medicine Limited and a successful IPO in FY24.
- Market Significance: Innova Captab plays a critical role in the Indian pharmaceutical ecosystem, providing manufacturing services for approximately 3,300 CDMO products and offering a portfolio of over 750 domestic branded generics. Its reach extends to 220,000+ pharmacy touchpoints.
- Revenue Breakdown (FY25 Consolidated):
- CDMO: ₹6,599 million (53% of revenue)
- Domestic Branded Generics: ₹2,239 million (18% of revenue)
- Sharon (Subsidiary): ₹1,989 million (16% of revenue)
- International Branded Generics: ₹1,617 million (13% of revenue)
- Total Revenue: ₹12,437 million (FY25) compared to ₹10,813 million in FY24.
- Financial Highlights:
- EBITDA: ₹1,982 million in FY25 (Margin: 15.9%).
- PAT: ₹1,283 million in FY25 (Margin: 10.3%).
- ROE: 13.4% in FY25.
- Key Products and Technology: The company focuses on diverse therapeutic areas and complex generics. It recently received GMP compliance certifications from UK-MHRA for its Cephalosporin unit in Baddi and from PIC/s (SMDC, Ukraine) for its Jammu facility.
- Subsidiaries: Key units include Univentis Medicare Limited and Sharon Bio-Medicine Limited.
- Strategic Initiatives: The company is expanding its international footprint, particularly in regulated markets like the UK and Canada. Strategic focus remains on increasing wallet share with existing CDMO clients and scaling up production at the new Jammu facility to meet growing demand.
References
